Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils

Clinical Rheumatology

Volumn 26, Issue 2, 2007, Pages 216-224

  Hsieh, S C ^a   Yu, H S ^a   Cheng, S H ^b   Li, K J ^c   Lu, M C ^c   Wu, C H ^a   Tsai, C Y ^c   Yu, C L ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Activation induced cell death; Anti neutrophil cytoplasmic autoantibody; Myeloperoxidase; Polymorphonuclear neutrophil; Proteinase 3

Indexed keywords

ENZYME ANTIBODY; GLUCOSE; HYDROGEN PEROXIDE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MYELOBLASTIN; MYELOBLASTIN ANTIBODY; MYELOPEROXIDASE; MYELOPEROXIDASE ANTIBODY; SUPEROXIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANCA ASSOCIATED VASCULITIS; APOPTOSIS; ARTICLE; CELL DEATH; CULTURE MEDIUM; CYTOKINE PRODUCTION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; LYMPHOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELLS, CULTURED; CHEMOKINES, CXC; DRUG COMBINATIONS; FLOW CYTOMETRY; GLUCOSE; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MYELOBLASTIN; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIDASE; PHAGOCYTOSIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845882486     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0285-3     Document Type: Article

References (56)

1. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW (1994) Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 46:1-15
2. Muller Kobold AC, van der Geld YM, Limburg PC, Tervaert JW, Kallenberg CG (1999) Pathophysiology of ANCA-associated glomerulonephritis. Nephrol Dial Transplant 14:1366-7135
3. Harper L, Savage COS (2000) Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 190:349-359
4. Kallenberg CG, Rarok A, Stegeman CA, Limburg PC (2002) New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmun Rev 1:61-66
5. Savage CO, Harper L, Holland M (2002) New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis. Curr Opin Rheumatol 14:15-22
6. Parok AA, Limburg PC, Kallenberg CG (2003) Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74:3-15
7. Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J et al (1989) Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461-2465
8. Egner W, Chapel HM (1990) Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Clin Exp Immunol 82:244-249
9. Jayne DR, Gaskin G, Pusey CD, Lockwood CM (1995) ANCA and predicting relapse in systemic vasculitis. Q J Med 88:127-133
10. Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW (2000) Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective study. Arthritis Rheum 43:2025-2033
11. Heeringa P, Brouwer E, Klok PA, Huitema MG, van den Born J, Weening JJ, Kallenberg CG (1996) Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol 149:1695-1706
12. Heeringa P, Brouwer E, Tervaert JW, Weening JJ, Kallenberg CG (1998) Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int 53:253-263
13. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955-963
14. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 120:12-17
15. Brons RH, Bakker HI, Van Wijk RT, Van Dijk NW, Muller Kobold AC, Limburg PC, Manson WL, Kallenberg CG, Tervaert JW (2000) Staphylococcal acid phosphatase binds to endothelial cells via charge interaction: A pathogenic role in Wegener's granulomatosis? Clin Exp Immunol 119:566-573
16. Hogan SL, Satterly KK, Dooley MA, Nachman PH, Jennette JC, Falk RJ (2001) Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 12:134-142
17. Ewert BH, Jennette JC, Falk RJ (1992) Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 41:375-383
18. Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87:4115-4119
19. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC (1991) Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 50:539-546
20. Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage CO (1996) IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: Relevance to systemic vasculitis. Clin Exp Immunol 106:273-279
21. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651-1657
22. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA (1989) Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74:1888-1893
23. Ludemann J, Utecht B, Gross WL (1990) Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357-362
24. Muller Kobold AC, Kallenberg CG, Tervaert JW (1998) Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis. Br J Rheumatol 37:901-907
25. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL (1994) Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95:244-250
26. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP (1994) Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153:1271-1280
27. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr (1985) Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 135:2069-2073
28. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
29. Martinez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Pineiro A, Naval J, Anel A (1998) Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 28:2714-2725
30. Monleon I, Martinez-Lorenzo MJ, Monteagudo L, Lasierra P, Taules M, Iturralde M, Pineiro A, Larrad L, Alava MA, Naval J, Anel A (2001) Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol 167:6736-6744
31. Hellmich B, Csernok E, Gross WL (2003) 20 years with ANCA (antineutrophil cytoplasmic autoantibodies): From seromarker to a major pathogenic player in vasculitis. J Leukoc Biol 74:1-2
32. Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 92:3007-3017
33. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365-376
34. Zhou Z, Richard C, Menard HA (2000) De novo synthesis of proteinase 3 by cytokine primed circulating human polymorphonuclear neutrophils and mononuclear cells. J Rheumatol 27:2406-2411
35. Burchert A, Wolfl S, Schmidt M, Brendel C, Denecke B, Cai D, Odyvanova L, Lahaye T, Muller MC, Berg T, Gschaidmeier H, Wittig B, Hehlmann R, Hochhaus A, Neubauer A (2003) Interferon-alpha, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia. Blood 101:259-264
36. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ (1995) Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: Relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86:3189-3195
37. Csernok E (2003) Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2:158-164
38. Harper L, Cockwell P, Adu D, Savage COS (2001) Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int 59:1729-1738
39. Luedke ES, Humes JL (1989) Effect of tumor necrosis factor on granule release and LTB4 production in adherent human polymorphonuclear leukocytes. Agents Actions 27:451-454
40. Hanlon WA, Stolk J, Davies P, Humes JL, Mumford R, Bonney RJ (1991) rTNF alpha facilitates human polymorphonuclear leukocyte adherence to fibrinogen matrices with mobilization of specific and tertiary but not azurophilic granule markers. J Leukoc Biol 50:43-48
41. Lloyd AR, Oppenheim JJ (1992) Poly's lament: The neglected role of the polymorphonuclear neutrophils in the afferent limb of the immune response. Immunol Today 13:169-172
42. Cassatella MA (1999) Production of cytokines by polymorphonuclear neutrophils. In: Gabrilovich DIN(ed) The neutrophils: new outlook for old cells. Imperial College Press, London, pp 151-229
43. Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049
44. Willems J, Joniau M, Cinque S, Van Damme J (1989) Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines. Immunology 67:540-542
45. Lee A, Whyte MK, Haslett C (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 54:283-288
46. Ben-Smith A, Dove SK, Martin A, Wakelam MJ, Savage CO (2001) Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fc gamma receptor ligation. Blood 98:1448-1455
47. Kettritz R, Choi M, Butt W, Rane M, Rolle S, Luft FC, Klein JB (2002) Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol 13:1740-1749
48. Kettritz R, Schreiber A, Luft FC, Haller H (2001) Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12:37-46
49. Moosig F, Csernok E, Kumanovics G, Gross WL (2000) Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha). Clin Exp Immunol 122:499-503
50. Harper L, Ren Y, Savill J, Adu D, Savage CO (2000) Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol 157:211-220
51. Patry YC, Trewick DC, Gregoire M, Audrain MA, Moreau AM, Muller JY, Meflah K, Esnault VL (2001) Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12:1764-1768
52. Rauova L, Gilburd B, Zurgil N, Blank M, Guegas LL, Brickman CM, Cebecauer L, Deutsch M, Wiik A, Shoenfeld Y (2002) Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes. Clin Immunol 103:69-78
53. Deutsch M, Guejes L, Zurgil N, Shovman O, Gilburd B, Afrimzon E, Shoenfeld Y (2004) Antineutrophil cytoplasmic autoantibodies penetrate into human polymorphonuclear leukocytes and modify their apoptosis. Clin Exp Rheumatol 22(6 Suppl 36):S35-S40
54. Hattar K, van Burck S, Bickenbach A, Grandel U, Maus U, Lohmeyer J, Csernok E, Hartung T, Seeger W, Grimminger F, Sibelius U (2005) Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation. J Leukoc Biol 78:992-1000
55. Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: Role of tumor necrosis factor-alpha. Am J Pathol 167:47-58
56. Miller SI, Ernst RK, Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3:36-46